Vasodilator therapy

August 7, 2017August 7, 2017

FDA OKs Trial Design of INOpulse Device as Treatment for Pulmonary Hypertension Linked to Lung Disease

News

The U.S. Food and Drug Administration has signed off on the design of a Phase 2b trial of INOpulse, a device that delivers nitric oxide, as a treatment for patients with pulmonary ... Read more

March 6, 2015March 6, 2015

PH Due to Langerhans Cell Histiocytosis May Benefit from Common PH Therapy, Case Study Shows

News

Researchers at the Mayo Clinic, Rochester, MN, published a clinical case study in which a novel therapeutic approach showed promising results in treating a fairly uncommon lung disease, known as ... Read more